Abstract
The effect of oral linoleic acid (LA) treatment on experimental allergic encephalomyelitis (EAE) in guinea-pigs in three trials of differing disease intensity has been investigated. The efficacy of LA treatment was linked to the severity of the disease being suppressed. The trial with the greatest disease severity showed no beneficial effect. The other two trials with less severe disease showed a marked therapeutic response to LA, but only when treatment was started before immunization and given continuously. This was apparent in both clinical and histopathological responses. These results support an immunoregulatory mechanism for LA treatment in EAE and by analogy in multiple sclerosis.
Full text
PDF








Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bates D., Fawcett P. R., Shaw D. A., Weightman D. Polyunsaturated fatty acids in multiple sclerosis. Br Med J. 1979 Mar 10;1(6164):683–683. doi: 10.1136/bmj.1.6164.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bates D., Fawcett P. R., Shaw D. A., Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J. 1978 Nov 18;2(6149):1390–1391. doi: 10.1136/bmj.2.6149.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bates D., Fawcett P. R., Shaw D. A., Weightman D. Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis. Br Med J. 1977 Oct 8;2(6092):932–933. doi: 10.1136/bmj.2.6092.932-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CASPARY E. A., FIELD E. J. AN ENCEPHALITOGENIC PROTEIN OF HUMAN ORIGIN: SOME CHEMICAL AND BIOLOGICAL PROPERTIES. Ann N Y Acad Sci. 1965 Mar 31;122:182–198. doi: 10.1111/j.1749-6632.1965.tb20202.x. [DOI] [PubMed] [Google Scholar]
- Clausen J., Moller J. Allergic encephalomyelitis induced by brain antigen after deficiency in polyunsaturated fatty acids during myelination. Int Arch Allergy Appl Immunol. 1969;36(Suppl):224–233. [PubMed] [Google Scholar]
- Field E. J., Joyce G. Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur Neurol. 1978;17(2):67–76. doi: 10.1159/000114926. [DOI] [PubMed] [Google Scholar]
- Field E. J., Joyce G., Smith B. M. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. J Neurol. 1977 Jan 13;214(2):113–127. doi: 10.1007/BF02430349. [DOI] [PubMed] [Google Scholar]
- Knight S. C. Cellular immunity in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):45–50. doi: 10.1093/oxfordjournals.bmb.a071395. [DOI] [PubMed] [Google Scholar]
- Maugh T. H., 2nd The EAE Model: A Tentative Connection to Multiple Sclerosis. Science. 1977 Mar 11;195(4282):969–971. doi: 10.1126/science.195.4282.969. [DOI] [PubMed] [Google Scholar]
- McHugh M. I., Wilkinson R., Elliott R. W., Field E. J., Dewar P., Hall R. R., Taylor R. M., Uldall P. R. Immunosuppression with polyunsaturated fatty acids in renal transplantation. Transplantation. 1977 Oct;24(4):263–267. doi: 10.1097/00007890-197710000-00005. [DOI] [PubMed] [Google Scholar]
- McIlhenny H. M., Levine S., Wiseman E. H., Sowinski R. Disposition and activity in experimental allergic encephalomyelitis of flumizole, a nonacidic, nonsteroidal, anti-inflammatory agent. Exp Neurol. 1978 Jan 1;58(1):126–137. doi: 10.1016/0014-4886(78)90128-0. [DOI] [PubMed] [Google Scholar]
- Meade C. J., Mertin J., Sheena J., Hunt R. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J Neurol Sci. 1978 Feb;35(2-3):291–308. doi: 10.1016/0022-510x(78)90010-2. [DOI] [PubMed] [Google Scholar]
- Mertin J., Hughes D. Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Int Arch Allergy Appl Immunol. 1975;48(2):203–210. doi: 10.1159/000231306. [DOI] [PubMed] [Google Scholar]
- Mertin J., Stackpoole A. Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by indomethacin. Prostaglandins Med. 1978 Oct;1(4):283–291. doi: 10.1016/0161-4630(78)90047-2. [DOI] [PubMed] [Google Scholar]
- Mertin J., Stackpoole A. The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors. Clin Exp Immunol. 1979 Jun;36(3):449–455. [PMC free article] [PubMed] [Google Scholar]
- Millar J. H., Zilkha K. J., Langman M. J., Wright H. P., Smith A. D., Belin J., Thompson R. H. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973 Mar 31;1(5856):765–768. doi: 10.1136/bmj.1.5856.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niewodniczy A., Poźniak-Patewicz E. Negatywne wyniki zastosowania indometacyny w leczeniu stwardnienia rozsianego. Neurol Neurochir Pol. 1973 Mar-Apr;7(2):291–291. [PubMed] [Google Scholar]
- Paty D. W., Cousin H. K., Read S., Adlakha K. Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neurol Scand. 1978 Jul;58(1):53–58. doi: 10.1111/j.1600-0404.1978.tb02859.x. [DOI] [PubMed] [Google Scholar]
- Pelus L. M., Strausser H. R. Prostaglandins and the immune response. Life Sci. 1977 Mar 15;20(6):903–913. doi: 10.1016/0024-3205(77)90274-0. [DOI] [PubMed] [Google Scholar]
- SINCLAIR H. M. Deficiency of essential fatty acids and atherosclerosis, etcetera. Lancet. 1956 Apr 7;270(6919):381–383. [PubMed] [Google Scholar]
- SWANK R. L. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci. 1950 Oct;220(4):421–430. [PubMed] [Google Scholar]
- Selivonchick D. P., Johnston P. V. Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. J Nutr. 1975 Mar;105(3):288–300. doi: 10.1093/jn/105.3.288. [DOI] [PubMed] [Google Scholar]
- Simon J., Contag I., Pöllinger G. Inhibition by polyunsaturated phospholipids of experimental allergic encephalomyelitis in the guinea pig. J Neurol Sci. 1979 Feb;40(2-3):113–122. doi: 10.1016/0022-510x(79)90197-7. [DOI] [PubMed] [Google Scholar]
- Spratt M. G., Kratzing C. C. Oleic acid as a depressant of reticuloendothelial activity in rats and mice. J Reticuloendothel Soc. 1975 Mar;17(3):135–140. [PubMed] [Google Scholar]
- Thompson R. H. A biochemical approach to the problem of multiple sclerosis. Proc R Soc Med. 1966 Mar;59(3):269–276. [PMC free article] [PubMed] [Google Scholar]
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
- Weyman C., Belin J., Smith A. D., Thompson R. H. Letter: Linoleic acid as an immunosuppressive agent. Lancet. 1975 Jul 5;2(7923):33–33. doi: 10.1016/s0140-6736(75)92977-3. [DOI] [PubMed] [Google Scholar]
- Wiśniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol. 1977 Feb;1(2):144–148. doi: 10.1002/ana.410010207. [DOI] [PubMed] [Google Scholar]